Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
Stürner KH, Stellmann JP, Dörr J, Paul F, Friede T, Schammler S, Reinhardt S, Gellissen S, Weissflog G, Faizy TD, Werz O, Fleischer S, Vaas LAI, Herrmann F, Pless O, Martin R, Heesen C. Stürner KH, et al. Among authors: heesen c. J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):330-338. doi: 10.1136/jnnp-2017-317101. Epub 2017 Dec 16. J Neurol Neurosurg Psychiatry. 2018. PMID: 29248894 Clinical Trial.
Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
Stürner KH, Siembab I, Schön G, Stellmann JP, Heidari N, Fehse B, Heesen C, Eiermann TH, Martin R, Binder TM. Stürner KH, et al. Among authors: heesen c. Mult Scler J Exp Transl Clin. 2019 Dec 9;5(4):2055217319894615. doi: 10.1177/2055217319894615. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31839982 Free PMC article.
Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research.
Dalgas U, Hvid LG, Kwakkel G, Motl RW, de Groot V, Feys P, Op't Eijnde B, Coote S, Beckerman H, Pfeifer K, Streber R, Peters S, Riemann-Lorenz K, Rosenkranz SC, Centonze D, Van Asch P, Bansi J, Sandroff BM, Pilutti LA, Ploughman M, Freeman J, Paul L, Dawes H, Romberg A, Kalron A, Stellmann JP, Friese MA, Heesen C. Dalgas U, et al. Among authors: heesen c. Mult Scler. 2020 Oct;26(11):1303-1308. doi: 10.1177/1352458520910360. Epub 2020 Mar 12. Mult Scler. 2020. PMID: 32162578 Free article.
Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
Rosenkranz SC, Gutmann L, Has Silemek AC, Dorr M, Häußler V, Lüpke M, Mönch A, Reinhardt S, Kuhle J, Tilsley P, Heesen C, Friese MA, Brandt A, Paul F, Zimmermann H, Stellmann JP. Rosenkranz SC, et al. Among authors: heesen c. J Neurol Neurosurg Psychiatry. 2023 Nov;94(11):924-933. doi: 10.1136/jnnp-2023-331183. Epub 2023 Jul 11. J Neurol Neurosurg Psychiatry. 2023. PMID: 37433662 Free article.
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
Bayas A, Berthele A, Blank N, Dreger P, Faissner S, Friese MA, Gerdes LA, Grauer OM, Häussler V, Heesen C, Janson D, Korporal-Kuhnke M, Kowarik M, Kröger N, Lünemann JD, Martin R, Meier U, Meuth S, Muraro P, Platten M, Schirmer L, Stürner KH, Stellmann JP, Scheid C, Bergh FT, Warnke C, Wildemann B, Ziemssen T. Bayas A, et al. Among authors: heesen c. Ther Adv Neurol Disord. 2023 Sep 28;16:17562864231180730. doi: 10.1177/17562864231180730. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37780055 Free PMC article.
Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life.
Braun B, Fischbach F, Richter J, Pfeffer LK, Fay H, Reinhardt S, Friese MA, Stellmann JP, Kröger NM, Heesen C, Häußler V. Braun B, et al. Among authors: heesen c. Mult Scler Relat Disord. 2024 Feb;82:105414. doi: 10.1016/j.msard.2023.105414. Epub 2023 Dec 27. Mult Scler Relat Disord. 2024. PMID: 38176284 Free article.
322 results